New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma. - Saito T; Kanao K; Matsumoto K; Fukumoto K; Igarashi D; Takahashi T; Kaneko G; Shirotake S; Nishimoto K; Mizuno R; Ishida M; Hara S; et al. (BJUI compass, 2023)